As of 2024-12-14, the Intrinsic Value of Initiator Pharma A/S (INIT.ST) is
-2.47 SEK. This INIT.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 7.10 SEK, the upside of Initiator Pharma A/S is
-134.83%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.47 SEK
Intrinsic Value
INIT.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.47 - -2.47 |
-2.47 |
-134.83% |
| P/E |
(6.57) - (7.10) |
(7.59) |
-206.9% |
| DDM - Stable |
(5.73) - 221.14 |
107.71 |
1417.0% |
| DDM - Multi |
(8.93) - 280.39 |
(18.88) |
-365.9% |
INIT.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
376.49 |
| Beta |
-0.14 |
| Outstanding shares (mil) |
53.03 |
| Enterprise Value (mil) |
354.04 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.92% |
| Cost of Debt |
5.00% |
| WACC |
6.77% |